Skip to content

6-KAccepted May 27, 7:12 AM ET

Agomab Therapeutics NV 6-K

AGMBAgomAb Therapeutics NV

Accepted (ET)

7:12 AM

May 27, 2026

Filed

May 27, 2026

Documents

3

Size

37.3 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.